Prevalence and stability of antibodies to 37 human papillomavirus types - A population-based longitudinal study

被引:36
|
作者
Antonsson, Annika [1 ]
Green, Adele C. [1 ]
Mallitt, Kylie-ann [1 ]
O'Rourke, Peter K. [1 ]
Pandeya, Nirmala [2 ]
Pawlita, Michael [3 ]
Waterboer, Tim [3 ]
Neale, Rachel E. [1 ]
机构
[1] Univ Queensland, Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[3] German Canc Res Ctr, Infect & Canc Program, D-69120 Heidelberg, Germany
基金
澳大利亚国家健康与医学研究理事会;
关键词
Human papillomavirus; Longitudinal study; Seroprevalence; Antibody stability; SQUAMOUS-CELL CARCINOMA; NONMELANOMA SKIN-CANCER; CUTANEOUS HUMAN PAPILLOMAVIRUSES; RENAL-TRANSPLANT RECIPIENTS; GLUTATHIONE-S-TRANSFERASE; EPIDERMODYSPLASIA-VERRUCIFORMIS; RISK-FACTORS; IMMUNOCOMPETENT INDIVIDUALS; ACTINIC KERATOSES; BASAL-CELL;
D O I
10.1016/j.virol.2010.07.046
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Information about serostability of cutaneous HPV types over time is very limited. We investigated seroprevalence and serostability of 37 different HPV types over 4 1/2 years in an Australian population-based study. Sera and data were analyzed for 390 people who had never been diagnosed with SCC and had blood collected in 1992, 1993 and 1996. Eighty-six percent of participants were seropositive to at least one of the 37 HPV types at baseline. HPV-4 was the type with the highest seroprevalence (41%), followed by HPV-38 and HPV-8 (both 33%). Over 90% of people retained their baseline serostatus during the 4 1/2 year follow-up. Highest serostability was observed for HPV-88 (99.7% stayed seropositive or seronegative), while HPV-65 was least stable with 17% altering their serostatus during follow-up. Seroprevalence to cutaneous HPV types are relatively stable over time, and a single measure can be used as a reasonable marker of long-term antibody status. (C) 2010 Published by Elsevier Inc.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [1] Prevalence of human papillomavirus in Indonesia: a population-based study in three regions
    Vet, J. N. I.
    de Boer, M. A.
    van den Akker, B. E. W. M.
    Siregar, B.
    Lisnawati
    Budiningsih, S.
    Tyasmorowati, D.
    Moestikaningsih
    Cornain, S.
    Peters, A. A. W.
    Fleuren, G. J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (01) : 214 - 218
  • [2] Prevalence of human papillomavirus in Indonesia: a population-based study in three regions
    J N I Vet
    M A de Boer
    B E W M van den Akker
    B Siregar
    S Lisnawati
    D Budiningsih
    S Tyasmorowati
    A A W Moestikaningsih
    G J Cornain
    British Journal of Cancer, 2008, 99 : 214 - 218
  • [3] Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand
    Sukvirach, S
    Smith, JS
    Tunsakul, S
    Muñoz, N
    Kesararat, V
    Opasatian, O
    Chichareon, S
    Kaenploy, V
    Ashley, R
    Meijer, CJLM
    Snijders, PJF
    Coursaget, P
    Franceschi, S
    Herrero, R
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (08): : 1246 - 1256
  • [4] Persistence of Concurrent Infections with Multiple Human Papillomavirus Types: A Population-based Cohort Study
    Campos, Nicole G.
    Cecilia Rodriguez, Ana
    Castle, Philip E.
    Herrero, Rolando
    Hildesheim, Allan
    Katki, Hormuzd
    Kim, Jane J.
    Wacholder, Sholom
    Morales, Jorge
    Burk, Robert D.
    Schiffman, Mark
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (06): : 823 - 827
  • [5] Prevalence of human papillomavirus infection among women in Concordia, Argentina:: A population-based study
    Matos, E
    Loria, D
    Amestoy, GM
    Herrera, L
    Prince, MA
    Moreno, J
    Krunfly, C
    Van den Brule, AJC
    Meijer, CJLM
    Muñoz, N
    Herrero, R
    SEXUALLY TRANSMITTED DISEASES, 2003, 30 (08) : 593 - 599
  • [6] A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination
    Wheeler, Cosette M.
    Hunt, William C.
    Cuzick, Jack
    Langsfeld, Erika
    Pearse, Amanda
    Montoya, George D.
    Robertson, Michael
    Shearman, Catherine A.
    Castle, Philip E.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 198 - 207
  • [7] Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study
    An, HJ
    Kim, KR
    Kim, IS
    Kim, DW
    Park, MH
    Park, IA
    Suh, KS
    Seo, EJ
    Sung, SH
    Sohn, JH
    Yoon, HK
    Chang, ED
    Cho, HI
    Han, JY
    Hong, SR
    Ahn, GH
    MODERN PATHOLOGY, 2005, 18 (04) : 528 - 534
  • [8] Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study
    Wei, Feixue
    Yin, Kai
    Wu, Xin
    Lan, Jian
    Huang, Shoujie
    Sheng, Wei
    Zhao, Jun
    Su, Yingying
    Wang, Ying
    Li, Yanping
    Li, Rongcheng
    Zhang, Jun
    Li, Mingqiang
    Wu, Ting
    Xia, Ningshao
    EMERGING MICROBES & INFECTIONS, 2016, 5 : 1 - 8
  • [9] Prevalence of Human Papillomavirus in Women Without Cervical Cancer: A Population-based Study in Eastern India
    Dutta, Sankhadeep
    Begum, Rakiba
    Mazumder, Dipanjana
    Mandal, Shyam Sundar
    Mondal, Ranajit
    Biswas, Jaydip
    Dey, Bindu
    Panda, Chinmay Kumar
    Basu, Partha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (02) : 186 - 191
  • [10] Prevalence of papillomavirus infection in women in Ibadan, Nigeria:: a population-based study
    Thomas, JO
    Herrero, R
    Omigbodun, AA
    Ojemakinde, K
    Ajayi, IO
    Fawole, A
    Oladepo, O
    Smith, JS
    Arslan, A
    Muñoz, N
    Snijders, PJF
    Meijer, CJLM
    Franceschi, S
    BRITISH JOURNAL OF CANCER, 2004, 90 (03) : 638 - 645